|
1
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. 8:e191–e203. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Di J, Rutherford S and Chu C: Review of the cervical cancer burden and population-based cervical cancer screening in China. Asian Pac J Cancer Prev. 16:7401–7407. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wen X, Liu S and Cui M: Effect of BRCA1 on the concurrent chemoradiotherapy resistance of cervical squamous cell carcinoma based on transcriptome sequencing analysis. BioMed Res Int. 2020:35984172020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang J, Zhang H and Jin S: Epigenetics and cervical cancer: From pathogenesis to therapy. Tumour Biol. 35:5083–5093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takekuma M, Kasamatsu Y, Kado N, Kuji S, Tanaka A, Takahashi N, Abe M and Hirashima Y: The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I–II cervical cancer: A review. J Obstet Gynaecol Res. 43:617–626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tewari AK, Stockert JA, Yadav SS, Yadav KK and Khan I: Inflammation and prostate cancer. Adv Exp Med Biol. 1095:41–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sadri Nahand J, Moghoofei M, Salmaninejad A, Bahmanpour Z, Karimzadeh M, Nasiri M, Mirzaei HR, Pourhanifeh MH, Bokharaei-Salim F, Mirzaei H, et al: Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review. Int J Cancer. 146:305–320. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie X, Yang M, Ding Y and Chen J: Microbial infection, inflammation and epithelial ovarian cancer. Oncol Lett. 14:1911–1919. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katoh M: Multi layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β catenin signaling activation (Review). Int J Mol Med. 42:713–725. 2018.PubMed/NCBI
|
|
12
|
Monkkonen T and Debnath J: Inflammatory signaling cascades and autophagy in cancer. Autophagy. 14:190–198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, Zhao W, Wang W, Lin S and Yang L: Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-kappaB and Erk pathway. Biomed Pharmacother. 92:429–436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
You L, Cui H, Zhao F, Sun H, Zhong H, Zhou G and Chen X: Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells. Bioengineered. 12:4995–5003. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Winograd R, Simeone DM and Bar-Sagi D: A novel target for combination immunotherapy in pancreatic cancer: IL-1β mediates immunosuppression in the tumour microenvironment. Br J Cancer. 124:1754–1756. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang B, Gui LS, Zhao XL, Zhu LL and Li QW: FOXO1 is a tumor suppressor in cervical cancer. Genet Mol Res. 14:6605–6616. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goto T and Takano M: Transcriptional role of FOXO1 in drug resistance through antioxidant defense systems. Adv Exp Med Biol. 665:171–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He A, Ji R, Shao J, He C, Jin M and Xu Y: TLR4-MyD88-TRAF6-TAK1 complex-mediated NF-κB activation contribute to the anti-inflammatory effect of V8 in LPS-induced human cervical cancer SiHa cells. Inflammation. 39:172–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao LJ, Gu PQ, Fan WM, Liu Z, Qiu F, Peng YZ and Guo XR: The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells. Int J Oncol. 39:1265–1272. 2011.PubMed/NCBI
|
|
21
|
Tyszka-Czochara M, Bukowska-Strakova K and Majka M: Metformin and caffeic acid regulate metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell cycle regulation. Food Chem Toxicol. 106:260–272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu XH, Wu LM, Wang JL, Dong XH, Zhang SC, Li XH, Xu H, Liu DB, Li ZH, Liu ZM, et al: Long non-coding RNA RP11-490M8.1 inhibits lipopolysaccharide-induced pyroptosis of human umbilical vein endothelial cells via the TLR4/NF-κB pathway. Immunobiology. 226:1521332021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Safe S, Nair V and Karki K: Metformin-induced anticancer activities: Recent insights. Biol Chem. 399:321–335. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nguyen TLL, Huynh DTN, Jin Y, Jeon H and Heo KS: Protective effects of ginsenoside-Rg2 and -Rh1 on liver function through inhibiting TAK1 and STAT3-mediated inflammatory activity and Nrf2/ARE-mediated antioxidant signaling pathway. Arch Pharm Res. 44:241–252. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu LM, Liang DY, Ye CG, Tu WJ and Zhu T: The UII/UT system mediates upregulation of proinflammatory cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated Kupffer cells. PLoS One. 10:e01213832015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen JQ, Zhang ZX, Shen CF and Liao JZ: Anticarcinogenic effect of Umbelliferone in human prostate carcinoma: An in vitro study. J BUON. 22:94–101. 2017.PubMed/NCBI
|
|
27
|
Veena VK, Popavath RN, Kennedy K and Sakthivel N: In vitro antiproliferative, pro-apoptotic, antimetastatic and anti-inflammatory potential of 2,4-diacetylphloroglucinol (DAPG) by Pseudomonas aeruginosa strain FP10. Apoptosis. 20:1281–1295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang M, Dong W, Li Z, Xiao Z, Xie Z, Ye Z, Liu S, Li R, Chen Y, Zhang L, et al: Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury. Am J Physiol Renal Physiol. 320:F262–F272. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moloney JN and Cotter TG: ROS signalling in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Poillet-Perez L, Despouy G, Delage-Mourroux R and Boyer-Guittaut M: Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol. 4:184–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang JB, Zhao ZB, Liu QZ, Hu TD, Long J, Yan K and Lian ZX: FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages. Oncogene. 37:1192–1204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM and Korswagen HC: Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science. 308:1181–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haj-Mirzaian A, Ramezanzadeh K, Tafazolimoghadam A, Kazemi K, Nikbakhsh R, Nikbakhsh R, Amini-Khoei H, Afshari K, Haddadi NS, Shakiba S, et al: Protective effect of minocycline on LPS-induced mitochondrial dysfunction and decreased seizure threshold through nitric oxide pathway. Eur J Pharmacol. 858:1724462019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mihaly SR, Ninomiya-Tsuji J and Morioka S: TAK1 control of cell death. Cell Death Differ. 21:1667–1676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu X, Cui Y, Li M, Xu H, Zuo J, Fang F and Chang Y: Cobalt protoporphyrin induces HO-1 expression mediated partially by FOXO1 and reduces mitochondria-derived reactive oxygen species production. PLoS One. 8:e805212013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li DX, Wang CN, Wang Y, Ye CL, Jiang L, Zhu XY and Liu YJ: NLRP3 inflammasome-dependent pyroptosis and apoptosis in hippocampus neurons mediates depressive-like behavior in diabetic mice. Behav Brain Res. 391:1126842020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi C, Wang Q, Rao Z, Shi Y, Wei S, Wang H, Lu X, Wang P, Lu L, Zhou H, et al: Diabetes induces hepatocyte pyroptosis by promoting oxidative stress-mediated NLRP3 inflammasome activation during liver ischaemia and reperfusion injury. Ann Transl Med. 8:7392020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oh S, Yang J, Park C, Son K and Byun K: Dieckol attenuated glucocorticoid-induced muscle atrophy by decreasing NLRP3 inflammasome and pyroptosis. Int J Mol Sci. 22:80572021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang H, Fang Z, Qu X, Zhang X and Wang Y: Procyanidin compound (PC) suppresses lipopolysaccharide-induced cervical cancer cell proliferation through blocking the TLR4/NF-κB pathway. Cancer Manag Res. 12:497–509. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Singh BK, Sinha RA, Zhou J, Tripathi M, Ohba K, Wang ME, Astapova I, Ghosh S, Hollenberg AN, Gauthier K, et al: Hepatic FOXO1 target genes are co-regulated by thyroid hormone via RICTOR protein deacetylation and MTORC2-AKT protein inhibition. J Biol Chem. 291:198–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang N, Qiu J, Zheng T, Zhang X, Hua K and Zhang Y: Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway. Oncol Rep. 39:1034–1042. 2018.PubMed/NCBI
|
|
42
|
Prasad SB, Yadav SS, Das M, Govardhan HB, Pandey LK, Singh S, Pradhan S and Narayan G: Down regulation of FOXO1 promotes cell proliferation in cervical cancer. J Cancer. 5:655–662. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zou J, Hong L, Luo C, Li Z, Zhu Y, Huang T, Zhang Y, Yuan H, Hu Y, Wen T, et al: Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway. Cancer Sci. 107:1806–1817. 2016. View Article : Google Scholar : PubMed/NCBI
|
